Literature DB >> 7507438

Novel actions of methylene blue.

B Mayer1, F Brunner, K Schmidt.   

Abstract

Methylene blue has been frequently used as an inhibitor of soluble guanylyl cyclase. We found that endothelium-dependent relaxations of isolated blood vessels were considerably more sensitive to inhibition by methylene blue than relaxation induced by direct activators of soluble guanylyl cyclase. Similar data were obtained in the presence of superoxide dismutase, indicating that the diverse potencies of methylene blue were not due to superoxide-induced inactivation of nitric oxide (NO). Subsequent experiments revealed that methylene blue is an inhibitor of purified NO synthase. Conversion of L-arginine to L-citrulline was inhibited by the dye in a concentration-dependent fashion with half-maximal effects observed at 5.3 microM and 9.2 microM in the absence and presence of superoxide dismutase, respectively. Purified soluble guanylyl cyclase, however, was far less sensitive to methylene blue. When the enzyme was maximally stimulated with S-nitroso-glutathione, cyclic guanosine monophosphate, (cGMP) formation was reduced by 50% at approximately 60 microM methylene blue; 1 mM produced maximal inhibitions of about 70%. Our data indicate that methylene blue is only a poor inhibitor of soluble guanylyl cyclase. The dye seems to act primarily via inhibition of NO synthase, with enzyme-bound heme being a possible target in its inhibitory action.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507438

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  28 in total

Review 1.  NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.

Authors:  Oleg V Evgenov; Pál Pacher; Peter M Schmidt; György Haskó; Harald H H W Schmidt; Johannes-Peter Stasch
Journal:  Nat Rev Drug Discov       Date:  2006-09       Impact factor: 84.694

2.  Reversal of the haemodynamic features of acute liver failure by methylene blue.

Authors:  P V McGinn
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

3.  Fever: an integrated response of the central nervous system to oxidative stress.

Authors:  W Riedel; G Maulik
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

4.  Cyclic GMP-dependent relaxation of isolated rat renal glomeruli induced by extracellular ATP.

Authors:  M Jankowski; M Szczepanska-Konkel; L Kalinowski; S Angielski
Journal:  J Physiol       Date:  2001-01-01       Impact factor: 5.182

5.  Methylene blue modulates adhesion molecule expression on microvascular endothelial cells.

Authors:  Isabella Werner; Fengwei Guo; Ulrich A Stock; Michèle Lupinski; Patrick Meybohm; Anton Moritz; Andres Beiras-Fernandez
Journal:  Inflamm Res       Date:  2014-05-03       Impact factor: 4.575

6.  Alternative mitochondrial electron transfer as a novel strategy for neuroprotection.

Authors:  Yi Wen; Wenjun Li; Ethan C Poteet; Luokun Xie; Cong Tan; Liang-Jun Yan; Xiaohua Ju; Ran Liu; Hai Qian; Marian A Marvin; Matthew S Goldberg; Hua She; Zixu Mao; James W Simpkins; Shao-Hua Yang
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157

Review 7.  Mitochondrial dysfunction--a pharmacological target in Alzheimer's disease.

Authors:  Gunter P Eckert; Kathrin Renner; Schamim H Eckert; Janett Eckmann; Stephanie Hagl; Reham M Abdel-Kader; Christopher Kurz; Kristina Leuner; Walter E Muller
Journal:  Mol Neurobiol       Date:  2012-05-03       Impact factor: 5.590

8.  Adenosine-mediated hypotension in in vivo guinea-pig: receptors involved and role of NO.

Authors:  P Nieri; E Martinotti; V Calderone; M C Breschi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  The effect on the intestines of continuous release of methylene blue from a drug delivery system: an experimental study in a chick embryo gastroschisis model.

Authors:  Ozgür Denli; Meral Barlas; Meltem Bingol-Kologlu; Aydin Yagmurlu; Sükrü Ozdamar; Canan Hasçiçek; Fatih Cedden
Journal:  Pediatr Surg Int       Date:  2004-08-26       Impact factor: 1.827

10.  The changes of the thyroid function and serum testosterone levels after long-term L-NAME treatment in male rats.

Authors:  M Haluzík; J Nedvídková; V Kopský; J Jahodová; B Horejsí; V Schreiber
Journal:  J Endocrinol Invest       Date:  1998-04       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.